We isolated a monoclonal antibody able to recognize carboxymethyl lysine (CML) which is the major antigenic AGE compound.
A sensitive immunoassay was developed to detect and quantify CML in biological samples.
A correlation between chronic kidney disease (CKD) grade and the CML concentration deduced from the immunoassay was observed.